← USPTO Trademark Applications

THERAVECTYS

Renewed TM79427841 Kind: renewed Mar 24, 2026

Abstract

Scientific research for medical purposes; research and development services for pharmaceutical preparations; conducting clinical trials in the nature of scientific research; clinical research for scientific purposes; conducting scientific feasibility studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.; Pharmaceutical and veterinary preparations for the treatment of cancer, infectious diseases and emerging infectious diseases; vaccines; pharmaceutical preparations containing lentiviral vectors for medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; chemical, biological and pharmaceutical preparations for therapeutic, medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; diagnostic preparations for therapeutic, medical and veterinary use; chemical reagents for medical or veterinary use.; Chemical preparations for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; lentiviral vectors for scientific research.; Medical analysis and medical diagnosis services for the treatment of cancer, infectious diseases and emerging infectious diseases; medical analyses of blood samples; medical assistance services relating to medicine and health care; provision of medical information.; Pharmaceutical product custom manufacturing to order for third parties; vaccine manufacturing services to order for third parties.

Filing Date

2025-05-15